We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.05B
AUM Growth
-$21.1M
Cap. Flow
+$10.7M
Cap. Flow %
1.01%
Top 10 Hldgs %
44.48%
Holding
56
New
1
Increased
14
Reduced
29
Closed
2

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.56M
2
BDX icon
Becton Dickinson
BDX
+$2.11M
3
OMC icon
Omnicom Group
OMC
+$2.1M
4
MMM icon
3M
MMM
+$1.94M
5
NVO
Novo Nordisk
NVO
+$1.92M

Sector Composition

Rank Sector Weight
1 Technology 29.76%
2 Healthcare 20.72%
3 Consumer Staples 18.04%
4 Industrials 15.72%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.73T
$60.6M 5.76%
1,371,873
-8,972
-0.6% -$409K
ORCL icon
2
Oracle
ORCL
$417B
$56.6M 5.38%
1,404,074
-5,659
-0.4% -$245K
CSCO icon
3
Cisco
CSCO
$476B
$48.9M 4.65%
1,779,449
-23,487
-1% -$674K
AAPL icon
4
Apple
AAPL
$4.47T
$47.7M 4.53%
1,519,716
+4,180
+0.3% +$134K
MDT icon
5
Medtronic
MDT
$115B
$45.8M 4.36%
618,579
-33,571
-5% -$2.56M
RTX icon
6
RTX Corp
RTX
$302B
$44.9M 4.27%
643,273
-3,070
-0.5% -$225K
BDX icon
7
Becton Dickinson
BDX
$49.2B
$44.8M 4.26%
323,958
-15,313
-5% -$2.11M
WMT icon
8
Walmart Inc
WMT
$895B
$41.2M 3.92%
1,742,634
+24,630
+1% +$628K
PG icon
9
Procter & Gamble
PG
$337B
$40.4M 3.84%
515,927
-8,387
-2% -$675K
ACN icon
10
Accenture
ACN
$109B
$37M 3.51%
381,824
-951
-0.2% -$90.9K
CHRW icon
11
C.H. Robinson
CHRW
$17B
$36M 3.43%
577,371
+20,072
+4% +$1.32M
OMC icon
12
Omnicom Group
OMC
$23.6B
$34.9M 3.32%
501,793
-27,758
-5% -$2.1M
MMM icon
13
3M
MMM
$94.5B
$34.3M 3.26%
265,987
-14,428
-5% -$1.94M
KO icon
14
Coca-Cola
KO
$373B
$33.7M 3.2%
858,844
-31,162
-4% -$1.27M
NVO
15
Novo Nordisk
NVO
$206B
$32.9M 3.13%
1,200,290
-68,474
-5% -$1.92M
VAR
16
DELISTED
Varian Medical Systems, Inc.
VAR
$32.5M 3.09%
438,884
+7,147
+2% +$560K
NKE icon
17
Nike
NKE
$60.7B
$31.1M 2.96%
576,666
-25,154
-4% -$1.29M
BAX icon
18
Baxter International
BAX
$14.3B
$30.7M 2.92%
807,652
+65,184
+9% +$2.44M
JNJ icon
19
Johnson & Johnson
JNJ
$624B
$30M 2.86%
308,294
-12,643
-4% -$1.27M
IBM icon
20
IBM
IBM
$225B
$29.1M 2.76%
186,875
-10,637
-5% -$1.71M
PEP icon
21
PepsiCo
PEP
$188B
$29M 2.76%
310,889
+23,895
+8% +$2.28M
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.11T
$26.5M 2.52%
194,611
+1,777
+0.9% +$253K
SYY icon
23
Sysco
SYY
$40.3B
$25.9M 2.47%
718,350
+74,808
+12% +$2.8M
PCP
24
DELISTED
PRECISION CASTPARTS CORP
PCP
$23.6M 2.25%
118,198
+105,944
+865% +$22.2M
SYK icon
25
Stryker
SYK
$134B
$21.2M 2.01%
221,430
+1,277
+0.6% +$121K

Similar funds

Saratoga Research & Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Saratoga Research & Investment Management held 56 positions worth $1.05B, down 2% from $1.07B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Saratoga Research & Investment Management's Q2 2015 filing shows 1 new, 14 increased, 29 reduced and 2 closed positions. Its largest new stake was Monmouth Real Estate Investment Corp: 33,760 shares worth $328K. The largest sale was Medtronic, an estimated $2.56M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management's largest Q2 2015 buy was Monmouth Real Estate Investment Corp: 33,760 shares worth $328K.
  • Saratoga Research & Investment Management added most to PRECISION CASTPARTS CORP in Q2 2015, an estimated $22.2M increase.
  • Saratoga Research & Investment Management's biggest Q2 2015 reduction was Medtronic, cutting an estimated $2.56M.
  • Saratoga Research & Investment Management fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $301K.
  • Saratoga Research & Investment Management's ten largest holdings make up 44% of its $1.05B portfolio in Q2 2015.
  • Saratoga Research & Investment Management opened 1 new position and closed 2 in Q2 2015.
  • Saratoga Research & Investment Management's portfolio value fell 2% quarter-over-quarter to $1.05B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2015, filed 17 Jul 2015.